Detalles de la búsqueda
1.
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.
Breast Cancer Res Treat
; 147(3): 513-25, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25200445
2.
A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy.
Br J Cancer
; 109(4): 859-65, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860530
3.
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).
Ann Oncol
; 20(5): 835-41, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19164456
4.
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.
Ann Oncol
; 20(9): 1483-1488, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19282468
5.
Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation.
J Clin Invest
; 82(1): 316-21, 1988 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-2839549
6.
Establishment of tumor cell lines as an independent prognostic factor for survival time in patients with small-cell lung cancer.
J Natl Cancer Inst
; 83(23): 1743-8, 1991 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-1663169
7.
Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer.
J Natl Cancer Inst
; 83(16): 1164-8, 1991 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-1653362
8.
Several new monoclonal antibodies directed to human T-cell leukemia antigens.
Cancer Res
; 42(10): 4259-62, 1982 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-6980703
9.
Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Cancer Res
; 41(7): 2973-6, 1981 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-6972802
10.
Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
Cancer Res
; 47(11): 2924-30, 1987 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3567910
11.
Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
Cancer Res
; 45(1): 358-64, 1985 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-2981159
12.
Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction.
Circulation
; 103(4): 555-61, 2001 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-11157722
13.
Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase.
Circulation
; 104(9): 979-81, 2001 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-11524388
14.
Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancer.
J Clin Oncol
; 18(16): 2996-3003, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10944133
15.
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
J Clin Oncol
; 13(4): 869-75, 1995 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7707113
16.
Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.
J Clin Oncol
; 12(8): 1547-52, 1994 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8040666
17.
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
J Clin Oncol
; 10(1): 16-20, 1992 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-1309380
18.
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
J Clin Oncol
; 10(11): 1775-80, 1992 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-1328551
19.
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.
J Clin Oncol
; 10(8): 1225-9, 1992 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1321891
20.
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
J Clin Oncol
; 9(4): 606-13, 1991 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1648597